O'Keeffe Charles B

CIK 00013786561 companyCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001378656

Recent Transactions

50 trades

Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-02-14−4,000→ 208,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14+4,000→ 732,470 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27+1,333→ 728,470 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-27−1,333→ 212,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-12-10−40,000→ 213,607 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-10$4.01/sh+40,000→ 727,137 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-09+1,413→ 687,137 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-09−1,413→ 253,607 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted stock units
2024-11-21+2,841→ 255,020 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-21+23,248→ 252,179 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-02-15+4,000→ 685,724 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-02-15−4,000→ 228,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-01-02−60,000→ 232,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-01-02$1.13/sh+60,000→ 681,724 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-27−1,333→ 292,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-12-27+1,333→ 621,724 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted stock units
2023-12-08+4,240→ 294,264 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-08+29,524→ 290,024 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-02-15+4,000→ 620,391 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-02-15−4,000→ 260,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-01-24−50,000→ 264,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-01-24$0.79/sh+50,000→ 616,391 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2022-12-27+15,000→ 310,500 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted stock units
2022-12-27+4,000→ 314,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-12-06−1,334→ 295,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2022-12-06+1,334→ 566,391 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2022-11-15$16.04/sh+87,985→ 565,057 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2022-08-18$2.53/sh+40,000→ 653,042 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2022-08-18−40,000→ 296,834 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-02-14+12,000→ 336,834 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2021-12-28+20,000→ 324,834 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2021-12-03−1,333→ 304,834 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2021-12-03+1,333→ 613,042 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2021-08-16$3.12/sh+50,000→ 611,709 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2021-08-16−50,000→ 306,167 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2020-12-30+30,000→ 356,167 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2020-12-22−1,333→ 326,167 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2020-12-22+1,333→ 561,709 total
Purchase
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2020-09-30$2.99/sh+7,000→ 560,376 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2019-12-02+33,500→ 323,500 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2019-12-02+4,000→ 327,500 total
Purchase
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2019-10-11$4.70/sh+10,000→ 553,376 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2018-12-19+25,000→ 290,000 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2018-12-19+25,000→ 265,000 total
Purchase
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2018-12-14$2.50/sh+20,000→ 543,376 total
Purchase
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2018-06-07$3.31/sh+4,000→ 522,376 total
Purchase
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2018-06-07$3.35/sh+1,000→ 523,376 total
Purchase
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2018-06-01$3.74/sh+5,000→ 518,376 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2018-01-02+20,000→ 240,000 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2018-01-02+20,000→ 220,000 total

Companies

CATALYST PHARMACEUTICALS, INC.
Director
$CPRX

Recent Filings

Address

355 ALHAMBRA CIRCLE, SUITE 1370

CORAL GABLES, FL, 33134

View on SEC.gov